"Designing Growth Strategies is in our DNA"

U.S. Viral Clearance Market Size, Share & Industry Analysis, By Method (Viral Removal Method, Viral Inactivation Method, and Viral Detection Method), By Application (Blood and Blood Products, Recombinant Proteins, Cellular & Gene Therapy Products, Vaccines, and Others), By End-user (Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CRO), and Others), and Country Forecast, 2024-2032

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI107888

 


To get information on various segments, share your queries with us

  ATTRIBUTE

  DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 18.7% from 2024 to 2032

Unit

Value (USD Million)

Segmentation

By Method

  • Viral Removal Method
  • Viral Inactivation Method
  • Viral Detection Method

By Application

  • Blood and Blood Products
  • Recombinant Proteins
  • Cellular & Gene Therapy Products
  • Vaccines
  • Others

By End-user

  • Pharmaceutical and Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CRO)
  • Others
  • 2019-2032
  • 2023
  • 2019-2022
  • 70
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann